News Focus
News Focus
Followers 27
Posts 6609
Boards Moderated 0
Alias Born 09/30/2012

Re: sunstar post# 321649

Tuesday, 01/02/2018 11:09:49 AM

Tuesday, January 02, 2018 11:09:49 AM

Post# of 347009
in humans?

Bavituximab provides that safety. Dr. Brekken of UTSW clearly stated that he saw a 200% to 300% increased response rate footprint where bavi was combined with other immunotherapies. That means increased efficacy and safety.

That's science, that's a fact.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y